As more specialty drugs enter the market each year, the increase in costs is in the billions—a concern for many patients who are managing complex, chronic conditions.

At this multi-stakeholder event, attendees collaborate and strategize ways to maintain a patient-centered approach to care in conjunction with the use of these high cost and high touch medications.

Our third annual meeting convenes health plans, providers, PBMs, and manufacturers to discuss how to increase drug pricing transparency, improve value-based contracting, and promote patient-centered care.